Nautilus Biotechnology, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
AH CAPITAL MANAGEMENT, L.L.C. | 11/13/2024 | 17.65 M | $50.31 M | 0.00% | 14.07% |
PERCEPTIVE ADVISORS LLC | 11/14/2024 | 12.59 M | $35.89 M | 0.00% | 10.04% |
CERCANO MANAGEMENT LLC | 11/14/2024 | 7.17 M | $20.44 M | 0.00% | 5.72% |
MADRONA VENTURE GROUP, LLC | 11/04/2024 | 6.02 M | $17.16 M | 0.00% | 4.80% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 3.57 M | $10.16 M | 100.00% | 2.84% |
VANGUARD GROUP INC | 11/13/2024 | 2.77 M | $7.88 M | 1.57% | 2.21% |
COMPREHENSIVE FINANCIAL MANAGEMENT LLC | 11/14/2024 | 2.21 M | $6.29 M | 0.00% | 1.76% |
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 11/14/2024 | 2.00 M | $5.70 M | 0.00% | 1.59% |
AMAZON COM INC | 11/07/2024 | 1.46 M | $4.15 M | 0.00% | 1.16% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.14 M | $3.24 M | 0.07% | 0.91% |
STATE STREET CORP | 11/14/2024 | 932,931 | $2.66 M | -0.88% | 0.74% |
TIKVAH MANAGEMENT LLC | 11/12/2024 | 726,895 | $2.07 M | 0.00% | 0.58% |
DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 691,986 | $1.97 M | 20.38% | 0.55% |
CLARIUS GROUP, LLC | 10/09/2024 | 636,532 | $1.81 M | 0.00% | 0.51% |
ARCHPOINT INVESTORS | 11/13/2024 | 614,271 | $1.75 M | 0.00% | 0.49% |
ALYESKA INVESTMENT GROUP, L.P. | 11/14/2024 | 441,018 | $1.26 M | 0.00% | 0.35% |
MORGAN STANLEY | 11/14/2024 | 400,488 | $1.14 M | 24.55% | 0.32% |
SENTINEL TRUST CO LBA | 10/15/2024 | 315,000 | $898,000 | 0.00% | 0.25% |
WEXFORD CAPITAL LP | 11/14/2024 | 228,350 | $650,798 | 9.60% | 0.18% |
HILLMAN CO | 10/21/2024 | 200,000 | $570,000 | 0.00% | 0.16% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 193,591 | $551,734 | 0.00% | 0.15% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 162,328 | $462,635 | 95.84% | 0.13% |
RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 154,700 | $440,895 | 10.42% | 0.12% |
CLEARLINE CAPITAL LP | 11/14/2024 | 144,187 | $410.93 M | -12.12% | 0.11% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 137,487 | $391,838 | 0.00% | 0.11% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 106,697 | $304,086 | -25.56% | 0.09% |
BARCLAYS PLC | 11/19/2024 | 106,174 | $303,000 | 79.61% | 0.08% |
CITADEL ADVISORS LLC | 11/14/2024 | 79,339 | $226,116 | 28.84% | 0.06% |
RHUMBLINE ADVISERS | 11/12/2024 | 70,886 | $202,019 | -5.00% | 0.06% |
CI PRIVATE WEALTH, LLC | 11/12/2024 | 45,350 | $129,248 | 0.00% | 0.04% |
JANE STREET GROUP, LLC | 11/15/2024 | 37,682 | $107,394 | -39.90% | 0.03% |
SIGNATUREFD, LLC | 10/21/2024 | 37,313 | $106,342 | 0.00% | 0.03% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 36,056 | $102,760 | 35.00% | 0.03% |
JPMORGAN CHASE & CO | 12/26/2024 | 35,603 | $101,469 | -5.35% | 0.03% |
VANGUARD CAPITAL WEALTH ADVISORS | 10/25/2024 | 35,000 | $99,750 | 0.00% | 0.03% |
METLIFE INVESTMENT MANAGEMENT, LLC | 11/13/2024 | 30,613 | $87,247 | 100.00% | 0.02% |
BADGLEY PHELPS WEALTH MANAGERS, LLC | 10/18/2024 | 30,000 | $85,500 | 0.00% | 0.02% |
UBS GROUP AG | 11/14/2024 | 27,781 | $79,176 | 37.85% | 0.02% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11/14/2024 | 26,662 | $75,987 | 2.42% | 0.02% |
COREBRIDGE FINANCIAL, INC. | 11/13/2024 | 26,050 | $74,243 | -0.61% | 0.02% |
WELLS FARGO & COMPANY/MN | 11/13/2024 | 26,032 | $74,191 | 19.93% | 0.02% |
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 10/25/2024 | 24,121 | $68,745 | 63.90% | 0.02% |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/13/2024 | 23,612 | $67,294 | 100.00% | 0.02% |
LAKE STREET ADVISORS GROUP, LLC | 10/23/2024 | 22,762 | $64,872 | 0.00% | 0.02% |
ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 21,460 | $61,161 | 3.37% | 0.02% |
INVESCO LTD. | 11/12/2024 | 20,620 | $58,768 | -2.94% | 0.02% |
PALUMBO WEALTH MANAGEMENT LLC | 10/28/2024 | 19,587 | $55,823 | 10.08% | 0.02% |
SG AMERICAS SECURITIES, LLC | 10/03/2024 | 17,579 | $50,000 | 100.00% | 0.01% |
PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 16,078 | $46,000 | 0.00% | 0.01% |
VOYA INVESTMENT MANAGEMENT LLC | 11/14/2024 | 13,096 | $37,324 | 0.00% | 0.01% |
Nautilus Biotechnology, Inc.institutional Ownership - FAQ's
During the previous two years, 82 institutional investors and hedge funds held shares of Nautilus Biotechnology, Inc.. The most heavily invested institutionals were:
AH Capital Management, L.L.C.: 17.65 M
PERCEPTIVE ADVISORS LLC: 12.59 M
Cercano Management LLC: 7.17 M
Madrona Venture Group, LLC: 6.02 M
BlackRock Funding, Inc. /DE: 3.57 M
VANGUARD GROUP INC: 2.77 M
51.17% of Nautilus Biotechnology, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 85.07 M shares in the last 24 months. This purchase volume represents approximately $151.43 M in transactions.